Harmony Biosciences Holdings (HRMY) Long-Term Debt Repayments (2022 - 2025)
Historic Long-Term Debt Repayments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to $3.8 million.
- Harmony Biosciences Holdings' Long-Term Debt Repayments changed 0.0% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $15.0 million for FY2024, which is 21578.95% up from last year.
- According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Long-Term Debt Repayments is $3.8 million, which was down 0.0% from $3.8 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Long-Term Debt Repayments registered a high of $3.8 million during Q4 2023, and its lowest value of $500000.0 during Q1 2022.
- In the last 4 years, Harmony Biosciences Holdings' Long-Term Debt Repayments had a median value of $3.8 million in 2023 and averaged $2.4 million.
- Within the past 5 years, the most significant YoY rise in Harmony Biosciences Holdings' Long-Term Debt Repayments was 65000.0% (2023), while the steepest drop was 0.0% (2023).
- Quarter analysis of 4 years shows Harmony Biosciences Holdings' Long-Term Debt Repayments stood at $500000.0 in 2022, then skyrocketed by 650.0% to $3.8 million in 2023, then changed by 0.0% to $3.8 million in 2024, then changed by 0.0% to $3.8 million in 2025.
- Its Long-Term Debt Repayments stands at $3.8 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.8 million for Q1 2025.